Intended for healthcare professionals


Three new treatments for diabetes recommended by NICE

BMJ 2016; 353 doi: (Published 25 May 2016) Cite this as: BMJ 2016;353:i2980
  1. Ingrid Torjesen
  1. London

The National Institute for Health and Care Excellence (NICE) has published final guidance recommending three drugs—canagliflozin (Invokana), dapagliflozin (Forxiga), and empagliflozin (Jardiance)—as treatment options for adults with type 2 diabetes if metformin, sulfonylurea, or pioglitazone are contraindicated or not tolerated.1

The three drugs could be used …

View Full Text

Log in

Log in through your institution


* For online subscription